These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2420431)

  • 1. Contribution of immunohistochemistry to the diagnosis of breast cancer in men.
    Aziz DC; Milne C; Solomon S; Jothy SP
    Can J Surg; 1986 Mar; 29(2):135-6. PubMed ID: 2420431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytology and immunocytochemistry of bilateral breast metastases from prostatic cancer. Report of a case.
    Schmitt FC; Tani E; Skoog L
    Acta Cytol; 1989; 33(6):899-902. PubMed ID: 2480045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical diagnosis of a case of metastatic prostate cancer to breast].
    Gotoh A; Matsuura K; Yoshimura S; Takano Y
    Nihon Hinyokika Gakkai Zasshi; 1989 Dec; 80(12):1828-31. PubMed ID: 2483185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of prostate-specific antigen in the management of localized prostatic cancer.
    Walsh PC; Oesterling JE; Epstein JI; Bruzek DJ; Rock RC; Chan DW
    Prog Clin Biol Res; 1989; 303():27-33. PubMed ID: 2476820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bilateral breast metastases from prostatic carcinoma: a case report].
    Soda T; Onishi H; Terachi T; Oishi K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1999 Apr; 45(4):269-71. PubMed ID: 10363149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
    Sheridan T; Herawi M; Epstein JI; Illei PB
    Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early prostate cancer antigen expression in predicting presence of prostate cancer in men with histologically negative biopsies.
    Hansel DE; DeMarzo AM; Platz EA; Jadallah S; Hicks J; Epstein JI; Partin AW; Netto GJ
    J Urol; 2007 May; 177(5):1736-40. PubMed ID: 17437801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 'Endometrial' adenocarcinoma of the prostatic urethra arising in a villous polyp. A light microscopic and immunoperoxidase study.
    Walker AN; Mills SE; Fechner RE; Perry JM
    Arch Pathol Lab Med; 1982 Nov; 106(12):624-7. PubMed ID: 6182857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization of prostate carcinoma-associated antigens.
    Wright GL; Beckett ML; Starling JJ; Schellhammer PF; Sieg SM; Ladaga LE; Poleskic S
    Cancer Res; 1983 Nov; 43(11):5509-16. PubMed ID: 6193873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features.
    Lane Z; Epstein JI; Ayub S; Netto GJ
    Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An immunohistochemical study of prostate antigen using an enzyme-labeled antibody technique].
    Okano M; Deguchi T; Takeuchi T; Kuriyama M; Nishiura T
    Hinyokika Kiyo; 1983 Oct; 29(10):1369-71. PubMed ID: 6085712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prostate-specific antigen in the diagnosis of prostatic carcinoma].
    Virseda JA; Morente M; Piris MA; Melchor AM; Gil Pascual B; Gómez A
    Actas Urol Esp; 1985; 9(1):89-94. PubMed ID: 2409752
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunohistochemical characterization of two monoclonal antibodies, P25.48 and P25.91, which define a new prostate-specific antigen.
    Bazinet M; Cote RJ; Cordon-Cardo C; Myc A; Fair WR; Old LJ
    Cancer Res; 1988 Dec; 48(23):6938-42. PubMed ID: 2460231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of prostatic markers. I. Classification of prostatic tumours using immunohistochemical techniques.
    Svanholm H; Hørder M
    Scand J Urol Nephrol Suppl; 1988; 107():65-70. PubMed ID: 2453920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
    Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
    Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast metastases of prostatic carcinoma: immunohistochemical case study.
    Fukutani K; Kawabe K; Matsuki K; Endo H; Mikata N; Yokoyama M
    Urol Int; 1987; 42(5):395-7. PubMed ID: 2448938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adenocarcinoma of the prostate].
    Dvorácek J
    Cas Lek Cesk; 1998 Aug; 137(17):515-21. PubMed ID: 9787503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synchronous male breast cancer and carcinoma of prostate in 90-year-old male, presented with spinal cord compression and multiple spine lytic lesions.
    Grenader T; Shavit L
    Breast J; 2007; 13(4):410-2. PubMed ID: 17593047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen. Current role in diagnostic pathology of prostate cancer.
    Bostwick DG
    Am J Clin Pathol; 1994 Oct; 102(4 Suppl 1):S31-7. PubMed ID: 7524305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.